SE8701294L - HIV peptide - Google Patents

HIV peptide

Info

Publication number
SE8701294L
SE8701294L SE8701294A SE8701294A SE8701294L SE 8701294 L SE8701294 L SE 8701294L SE 8701294 A SE8701294 A SE 8701294A SE 8701294 A SE8701294 A SE 8701294A SE 8701294 L SE8701294 L SE 8701294L
Authority
SE
Sweden
Prior art keywords
hiv
peptide
cys
leu
gln
Prior art date
Application number
SE8701294A
Other languages
Swedish (sv)
Other versions
SE8701294D0 (en
SE468181B (en
Inventor
A Vahlne
Original Assignee
Virovahl Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virovahl Sa filed Critical Virovahl Sa
Priority to SE8701294A priority Critical patent/SE468181B/en
Publication of SE8701294D0 publication Critical patent/SE8701294D0/en
Priority to NO881151A priority patent/NO881151L/en
Priority to FI881418A priority patent/FI881418A/en
Priority to ZA882095A priority patent/ZA882095B/en
Priority to AU13807/88A priority patent/AU606928B2/en
Priority to CA000562531A priority patent/CA1336473C/en
Priority to ES8800920A priority patent/ES2013328A6/en
Priority to NZ224046A priority patent/NZ224046A/en
Priority to DK164088A priority patent/DK164088A/en
Priority to SU884355648A priority patent/RU1802871C/en
Priority to EP19880850105 priority patent/EP0284587A3/en
Publication of SE8701294L publication Critical patent/SE8701294L/en
Priority to ZA892301A priority patent/ZA892301B/en
Publication of SE468181B publication Critical patent/SE468181B/en
Priority to CA000616876A priority patent/CA1338028C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A synthetic antigen in the form of a peptide, the sequence of which corresponds to parts of the proteins of the HIV-1 virus and which peptide has the formula: Asp-Gln-Gln-Leu-Leu-Ile-Trp-Gly-Cys-Ser-Gly-Lys-Leu-Ile- Cys-Thr-Thr-Ala-Val-Pro-Trp-Asn-Cys-OH. The peptide is immunoreactive with HIV-1-specific antibodies and intended to be used for diagnosis of HIV-1 and also to give rise to production of antibodies to HIV- 1 in animals and humans. <IMAGE>
SE8701294A 1987-03-27 1987-03-27 HIV-1 gp41 peptide, vaccine and antigen containing the peptide and also diagnostic test using the peptide SE468181B (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE8701294A SE468181B (en) 1987-03-27 1987-03-27 HIV-1 gp41 peptide, vaccine and antigen containing the peptide and also diagnostic test using the peptide
NO881151A NO881151L (en) 1987-03-27 1988-03-16 SYNTHETIC HIV-1 ANTIGEN.
FI881418A FI881418A (en) 1987-03-27 1988-03-24 SYNTHETIC PEPTID ANTIGENER FOER FASTSTAELLANDE AV HIV-1 INFEKTION.
ZA882095A ZA882095B (en) 1987-03-27 1988-03-24 Synthetic peptide antigens for the detection of hiv-1 infection
SU884355648A RU1802871C (en) 1987-03-27 1988-03-25 Method of determination of antibody to hiv-1
ES8800920A ES2013328A6 (en) 1987-03-27 1988-03-25 Synthetic peptide antigens for the detection of HIV-1 infection.
CA000562531A CA1336473C (en) 1987-03-27 1988-03-25 Synthetic peptide antigens for the detection of hiv-1 infection
AU13807/88A AU606928B2 (en) 1987-03-27 1988-03-25 Synthetic peptide antigens for the detection of hiv-1 infection
NZ224046A NZ224046A (en) 1987-03-27 1988-03-25 Hiv antigenic peptide fragments and their use
DK164088A DK164088A (en) 1987-03-27 1988-03-25 SYNTHETIC PEPTID ANTIGEN FOR DETECTIVE HIV-1 INFECTION
EP19880850105 EP0284587A3 (en) 1987-03-27 1988-03-28 Synthetic peptide antigens for the detection of hiv-1 infection
ZA892301A ZA892301B (en) 1987-03-27 1989-03-29 Synthetic peptide antigens for the detection of htlv-1 infection
CA000616876A CA1338028C (en) 1987-03-27 1994-06-09 Synthetic peptide antigens for the detection of hiv-1 infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8701294A SE468181B (en) 1987-03-27 1987-03-27 HIV-1 gp41 peptide, vaccine and antigen containing the peptide and also diagnostic test using the peptide

Publications (3)

Publication Number Publication Date
SE8701294D0 SE8701294D0 (en) 1987-03-27
SE8701294L true SE8701294L (en) 1988-09-28
SE468181B SE468181B (en) 1992-11-16

Family

ID=20368020

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8701294A SE468181B (en) 1987-03-27 1987-03-27 HIV-1 gp41 peptide, vaccine and antigen containing the peptide and also diagnostic test using the peptide

Country Status (2)

Country Link
SE (1) SE468181B (en)
ZA (1) ZA882095B (en)

Also Published As

Publication number Publication date
SE8701294D0 (en) 1987-03-27
SE468181B (en) 1992-11-16
ZA882095B (en) 1989-10-25

Similar Documents

Publication Publication Date Title
NO881719L (en) SYNTHETIC HIV-2 ANTIGEN.
DK614987A (en) SYNTHETIC HTLV-III PEPTIDES, PREPARATIONS AND APPLICATIONS THEREOF
ES2013328A6 (en) Synthetic peptide antigens for the detection of HIV-1 infection.
DE68926300D1 (en) NEW VIRUS, RESPONSIBLE FOR THE INFECTIOUS DISEASE OF BURSA FABRICIUS
ATE82509T1 (en) ORAL VACCINES.
DE69013950D1 (en) Monoclonal antibody to differentiate HIV-2 seropositive from HIV-1 seropositive individuals.
DE69033080D1 (en) INCREASING FACTOR RECIPES DERIVED FROM TYPE OC PLATES
ATE119203T1 (en) MONOCLONAL ANTIBODIES OF MOUSE AGAINST THE GP41 PROTEIN OF HUMAN IMMUNE DEFICIENCY SYNDROME VIRUS.
ATE90689T1 (en) FRAGMENT OF HEPATITIS B INTERNAL BODY ANTIGENS.
SE8701294D0 (en) HIV peptide
KR890700683A (en) Methods for searching for antibodies against human immunodeficiency virus
ES2074983T3 (en) PROCEDURE FOR THE ISOLATION OF BASAL MEMBRANE PROTEINS FROM HUMAN AND ANIMAL TISSUES.
ATE4282T1 (en) PROCESS FOR THE MANUFACTURE OF TOXOPLASM PREPARATIONS FOR TOXOPLASMOS DIAGNOSIS AND THE PREPARATIONS SO MADE.
NZ235474A (en) Virus capable of inducing infectious bursal disease; assay and vaccine
WO1989009227A3 (en) Pf10 to pf19 peptides of an hiv retrovirus, process for synthetizing said peptides and their use, in particular for diagnosis
NO881661L (en) HUMAN RHINOVIRUS Peptides.
LV10626A (en) Peptide
GB916455A (en) Non-toxic antigens and process for producing same
ATE123036T1 (en) METHOD FOR IN VITRO DIAGNOSIS OF HIV-1 VIRUS INFECTIONS.
ES2155436T3 (en) RECOMBINANT PROTEINS WITH THE IMMUNOLOGICAL REACTIVITY OF THE ANTIGEN AND THE VIRUS OF HEPATITIS B (HBEAG), PROCEDURE FOR PREPARATION AND USE IN IMMUNOLOGICAL ANALYSIS AND IN VACCINES.
RU95101596A (en) Strain &#34;m-92&#34; of infectious bursal turkey disease - family birnoviridae
FI883765A (en) ANTIKROPPAR MOT BIOLOGISKT AKTIVA POLYPEPTIDER OCH DERAS ANVAENDNING VID DIAGNOSTISKA FOERFARANDEN.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8701294-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8701294-4

Format of ref document f/p: F